These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4548551)

  • 21. Effects of a delta9-tetrahydrocannabinol (delta9-THC) metabolite on bone marrow myelopoiesis.
    Johnson RJ; Wiersema V
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):393-6. PubMed ID: 4851725
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of delta9-tetrahydrocannabinol on the metabolism of 3H-5-hydroxytryptamine and 3H-norepinephrine in the rat brain.
    Ho BT; Taylor D; Englert LF
    Res Commun Chem Pathol Pharmacol; 1974 Apr; 7(4):645-50. PubMed ID: 4828760
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis and characterization of glucuronides of 5'-hydroxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-tetrahydrocannabinol.
    Pallante S; Lyle MA; Fenselau C
    Drug Metab Dispos; 1978; 6(4):389-95. PubMed ID: 28918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Enzymatic changes induced by cannabis].
    Ortega-Corona BG
    Arch Invest Med (Mex); 1974; 5 SUPPL 1():195-204. PubMed ID: 4614732
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol.
    Lemberger L; Martz R; Rodda B; Forney R; Rowe H
    J Clin Invest; 1973 Oct; 52(10):2411-7. PubMed ID: 4729039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Some behavioral effects of delta9 -tetrahydrocannabinol in rats.
    Pradhan SN; Bailey PT; Ghosh B
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):197-204. PubMed ID: 4610672
    [No Abstract]   [Full Text] [Related]  

  • 27. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice.
    Luszczki JJ; Mohamed M; Czuczwar SJ
    Eur J Pharmacol; 2006 Feb; 531(1-3):66-73. PubMed ID: 16403497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of antiepileptic drugs on brain energy reserves during convulsions.
    King LJ; Carl J
    J Neurochem; 1969 Apr; 16(4):637-43. PubMed ID: 5768218
    [No Abstract]   [Full Text] [Related]  

  • 29. Modification of the effects of 9 -tetrahydrocannabinol by phenobarbital pretreatment in mice.
    Fujimoto JM
    Toxicol Appl Pharmacol; 1972 Dec; 23(4):623-34. PubMed ID: 4644697
    [No Abstract]   [Full Text] [Related]  

  • 30. Proceedings: The effect of delta-1-tetrahydrocannabinol on the noradrenaline and dopamine content of the brain and heart of the rat.
    Graham JD; Lewis MJ; Williams J
    Br J Pharmacol; 1974 Nov; 52(3):446P. PubMed ID: 4458861
    [No Abstract]   [Full Text] [Related]  

  • 31. In vivo effect of LSD, morphine, ethanol and delta9-tetrahydrocannabinol on mouse brain adenosine triphosphatase activity.
    Jain ML; Curtis BM; Bakutis EV
    Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):229-32. PubMed ID: 4272745
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on the metabolism of the Delta9-tetrahydrocannabinol precursor Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) in rat using LC-MS/MS, LC-QTOF MS and GC-MS techniques.
    Jung J; Meyer MR; Maurer HH; Neusüss C; Weinmann W; Auwärter V
    J Mass Spectrom; 2009 Oct; 44(10):1423-33. PubMed ID: 19728318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenytoin antagonism of electrically induced maximal seizures in frogs and mice and effects on central nervous system levels of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate.
    Johnson SW; Riker WK
    J Pharmacol Exp Ther; 1982 Apr; 221(1):139-45. PubMed ID: 6278134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Separate radioimmune measurements of body fluid delta9-THC and 11-nor-9-carboxy-delta9-THC.
    Gross SJ; Soares JR
    NIDA Res Monogr; 1976 May; (7):10-4. PubMed ID: 967237
    [No Abstract]   [Full Text] [Related]  

  • 35. Evidence for a synergistic interaction between phenytoin and phenobarbital in experimental animals.
    Masuda Y; Utsui Y; Shiraishi Y; Karasawa T; Yoshida K; Shimizu M
    J Pharmacol Exp Ther; 1981 Jun; 217(3):805-11. PubMed ID: 7230008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Asymmetrical effect of delta-9-tetrahydrocannabinol (THC) on striatal dopamine and behavior.
    Waters DH; Glick SD
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):57-63. PubMed ID: 4734017
    [No Abstract]   [Full Text] [Related]  

  • 37. Isobolographic analysis of interactions between remacemide and conventional antiepileptic drugs in the mouse model of maximal electroshock.
    Borowicz KK; Malek R; Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsy Behav; 2007 Aug; 11(1):6-12. PubMed ID: 17602881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the anticonvulsant, neurotoxic and lethal effects of diphenylbarbituric acid, phenobarbital and diphenylhydantoin in the mouse.
    Raines A; Niner JM; Pace DG
    J Pharmacol Exp Ther; 1973 Aug; 186(2):315-22. PubMed ID: 4719784
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolism and anticonvulsant properties of primidone in the rat.
    Baumel IP; Gallagher BB; DiMicco J; Goico H
    J Pharmacol Exp Ther; 1973 Aug; 186(2):305-14. PubMed ID: 4719783
    [No Abstract]   [Full Text] [Related]  

  • 40. The changes in vitamin B6 and brain amine metabolism in mice chronically treated with delta-9-tetrahydrocannabinol.
    Colombini CE; Westfall TC; McCoy EE
    Act Nerv Super (Praha); 1974 Mar; 16(1):68-9. PubMed ID: 4454949
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.